Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011;6(7):e22092.
doi: 10.1371/journal.pone.0022092. Epub 2011 Jul 19.

The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis

Ping Zhou  1 , Guo-Qiang Lv, Jian-Zhong Wang, Cheng-Wan Li, Liang-Feng Du, Chun Zhang, Jian-Ping Li
Affiliations
Meta-Analysis

The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis

Ping Zhou et al. PLoS One. 2011.

Abstract

Background and objectives: Tumor necrosis factor-α (TNF-α) plays a very important role in the development and progress of cancer. Some TNF-α polymorphisms have been confirmed to increase cancer risks; however, the association between TNF-α-238 polymorphism and cancers remains controversial and ambiguous. The aim of this study is to explore a more precise estimation of its relationship with cancer using meta-analysis.

Methods: Electronic searches of several databases were conducted for all publications on the association between this variant and cancer through March 2011. Odds ratios (OR) with 95% confidence intervals (95% CI) were used to access the strength of this association in the random-effect model.

Results: Thirty four studies with 34,679 cancer patients and 41,186 healthy controls were included. This meta-analysis showed no significant association between TNF-α-238 polymorphism and cancers (AA+GA vs GG: OR = 1.09, 95%CI = 0.88-1.34). In Caucasian and Asian subgroups, OR values (95% CI) were 1.14 (0.91-1.43) and 0.97 (0.58-1.61), respectively. In the subgroups of cancer type, no significant association was detected. The sensitivity analysis further strengthened the validity of these negative associations. No publication bias was observed in this study.

Conclusions: No significant association was found between the TNF-α-238 polymorphism and the risk for cancer.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. ORs and 95% confidence interval (CI) of cancer according to TNF-α-238 polymorphism in 34 studies using random-effect model.
AA+GA, AA and GA genotypes of TNF-α-238 polymorphism; GG, GG genotype of TNF-α-238 polymorphism; ORs, odds ratios.
Figure 2
Figure 2. Funnel plots analysis to detect publication bias.
Each point represents an independent study for the indicated association.
See this image and copyright information in PMC

References

    1. Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314–320. - PubMed
    1. Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009;4:e5360. - PMC - PubMed
    1. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997;72:149–153. - PubMed
    1. Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, et al. A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol. 2005;100:2644–2649. - PubMed
    1. Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, et al. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One. 2008;3:e2546. - PMC - PubMed

Publication types

Substances